Destructive Breast Relapse of Diffuse Large B-cell Lymphoma After Complete Remission: Surgical and Reconstructive Management
Breast involvement in diffuse large B-cell lymphoma (DLBCL) is rare, and breast relapse after complete remission is particularly uncommon. DLBCL is treated primarily with systemic immunochemotherapy, but surgery may be indicated for severe local complications. We report a woman diagnosed with DLBCL at the age of 41 years who developed a breast relapse seven years after a second complete metabolic response. She presented with a massive ulcerated, necrotic, and bleeding lesion involving over 50% of the left breast and the nipple-areolar complex. Histopathological examination confirmed recurrent DLBCL, and positron emission tomography/computed tomography (PET/CT) showed nodal involvement without confirmed distant disease. Given the extent of tissue destruction, bleeding, and risk of secondary infection, multidisciplinary consultation recommended mastectomy with axillary lymph node dissection and immediate reconstruction with a pedicled latissimus dorsi flap. The flap survived completely, and the only complication was a small donor-site seroma that resolved with conservative management. Six cycles of R-DHAP (rituximab, dexamethasone, cytarabine, and cisplatin) were started one month after surgery without radiotherapy. At one year of follow-up, the flap was viable, and the patient was doing well. This case illustrates that radical surgery with immediate reconstruction may be considered as a complement to systemic therapy in selected patients with breast DLBCL when severe local complications require surgical intervention.
Authors
- Maria Kharbouch
- Mounia El Omari
- Hamza Tazi
- Rita Ait Benhamou
- Hind Souiheb
Institutions
- Université Mohammed VI des Sciences et de la Santé (MA)
- Hôpital Universitaire International Cheikh Khalifa (MA)
Publication Details
- Journal
- Cureus
- Published
- 2026-11-17
- DOI
- https://doi.org/10.7759/cureus.119821
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00